Surveillance of women at high risk for hereditary ovarian cancer is inefficient-Reference-Cited by-同舟云学术

Surveillance of women at high risk for hereditary ovarian cancer is inefficient

Published:2006-02-21 Issue:6 Volume:94 Page:814-819
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Oei A L,Massuger L F,Bulten J,Ligtenberg M J,Hoogerbrugge N,de Hullu J A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603015.pdf

Reference24 articles.

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, nton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117–1130

2. Bourne TH, Whitehead MI, Campbell S, Royston P, Bhan V, Collins WP (1991) Ultrasound screening for familial ovarian cancer. Gynecol Oncol 43: 92–97

3. Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 112: 357–364

4. Dorum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R, Schiefloe A, Hagen B, Himmelmann A, Jerve F, Shetelig K, Fjaerestad I, Trope C, Moller P (1999) Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 78: 906–911

5. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457–1462

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review;Cancer Medicine;2024-07

2. CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal study;2024-05-31

3. Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review;Journal of Clinical Medicine;2023-02-10

4. Contraceptives and cancer risks inBRCA1/2pathogenic variant carriers: a systematic review and meta-analysis;Human Reproduction Update;2022-11-16

5. Hereditary Cancer Syndromes—A Broader Clinical Spectrum Than Previously Understood?;JAMA Oncology;2022-11-01